BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 21146391)

  • 21. Endoplasmic reticulum proteostasis: a key checkpoint in cancer.
    Oakes SA
    Am J Physiol Cell Physiol; 2017 Feb; 312(2):C93-C102. PubMed ID: 27856431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular chaperones as therapeutic targets to counteract proteostasis defects.
    Cattaneo M; Dominici R; Cardano M; Diaferia G; Rovida E; Biunno I
    J Cell Physiol; 2012 Mar; 227(3):1226-34. PubMed ID: 21618531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aging as an event of proteostasis collapse.
    Taylor RC; Dillin A
    Cold Spring Harb Perspect Biol; 2011 May; 3(5):. PubMed ID: 21441594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Misfolding of Proteins.
    Argyrou A
    Adv Exp Med Biol; 2020; 1195():249-254. PubMed ID: 32468483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Model systems of protein-misfolding diseases reveal chaperone modifiers of proteotoxicity.
    Brehme M; Voisine C
    Dis Model Mech; 2016 Aug; 9(8):823-38. PubMed ID: 27491084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Organismal Protein Homeostasis Mechanisms.
    Hoppe T; Cohen E
    Genetics; 2020 Aug; 215(4):889-901. PubMed ID: 32759342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular chaperone functions in protein folding and proteostasis.
    Kim YE; Hipp MS; Bracher A; Hayer-Hartl M; Hartl FU
    Annu Rev Biochem; 2013; 82():323-55. PubMed ID: 23746257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent developments in targeting protein misfolding diseases.
    Denny RA; Gavrin LK; Saiah E
    Bioorg Med Chem Lett; 2013 Apr; 23(7):1935-44. PubMed ID: 23454013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibiting toxic aggregation of amyloidogenic proteins: a therapeutic strategy for protein misfolding diseases.
    Cheng B; Gong H; Xiao H; Petersen RB; Zheng L; Huang K
    Biochim Biophys Acta; 2013 Oct; 1830(10):4860-71. PubMed ID: 23820032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis.
    Marinko JT; Huang H; Penn WD; Capra JA; Schlebach JP; Sanders CR
    Chem Rev; 2019 May; 119(9):5537-5606. PubMed ID: 30608666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adapting Secretory Proteostasis and Function Through the Unfolded Protein Response.
    Wong MY; DiChiara AS; Suen PH; Chen K; Doan ND; Shoulders MD
    Curr Top Microbiol Immunol; 2018; 414():1-25. PubMed ID: 28929194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein misfolding in disease and small molecule therapies.
    Gomes CM
    Curr Top Med Chem; 2012; 12(22):2460-9. PubMed ID: 23339300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical and biological approaches synergize to ameliorate protein-folding diseases.
    Mu TW; Ong DS; Wang YJ; Balch WE; Yates JR; Segatori L; Kelly JW
    Cell; 2008 Sep; 134(5):769-81. PubMed ID: 18775310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rare ER protein misfolding-mistrafficking disorders: Therapeutic developments.
    Hegde RN; Subramanian A; Pothukuchi P; Parashuraman S; Luini A
    Tissue Cell; 2017 Apr; 49(2 Pt A):175-185. PubMed ID: 28222887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha 1-Antitrypsin Deficiency: A Disorder of Proteostasis-Mediated Protein Folding and Trafficking Pathways.
    Karatas E; Bouchecareilh M
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stress-responsive regulation of extracellular proteostasis.
    Mesgarzadeh JS; Buxbaum JN; Wiseman RL
    J Cell Biol; 2022 Apr; 221(4):. PubMed ID: 35191945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of cell-non-autonomous proteostasis in metazoans.
    O'Brien D; van Oosten-Hawle P
    Essays Biochem; 2016 Oct; 60(2):133-142. PubMed ID: 27744329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic Uses of Bacterial Subunit Toxins.
    Lingwood C
    Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34073185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential Influence of Cyclo(His-Pro) on Proteostasis: Impact on Neurodegenerative Diseases.
    Grottelli S; Costanzi E; Peirce MJ; Minelli A; Cellini B; Bellezza I
    Curr Protein Pept Sci; 2018; 19(8):805-812. PubMed ID: 29708066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small-molecule modulation of cellular chaperones to treat protein misfolding disorders.
    Sloan LA; Fillmore MC; Churcher I
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):666-81. PubMed ID: 19736625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.